Want to track AKBA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Akebia Therapeutics Inc. (AKBA) Statistics
Valuation metrics
Market Cap 246.48M
Enterprise value 134.11M
Trailing P/E (ttm) -8.14
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 1.08
Price/Book (mrq) 9.47
Enterprise Value/Revenue 0.61
Enterprise Value/EBITDA -7.45
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.17M
Average volume (90 days) 4.67M
Price summary
52-Week low 0.81
52-Week high 3.22
Beta -
50-Day moving average 1.09
200-Day moving average 1.24
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.14%
Operating margin -0.07%
Operational effectiveness
Return on assets -0.08%
Return on equity -0.94%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.81
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.58
Total debt (mrq) -
Total Debt/Equity (mrq) 2.16
Current ratio (mrq) 1.43%
Book value per share (mrq) 0.09
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
